6-Fluoro-2-methyl-1,3-benzothiazole-5-carbaldehyde, 98%, 500mg

(S)-2-Acetoxy-3-phenylpropanoic acid, 97%, 250mg

1-(2-Chloroethyl)azetidine hydrochloride, 95+%, 100mg

(+)-trans-Limonene oxide, 98%, 100mg

diethyl 2-acetamido-2-(4-(1,3-dioxoisoindolin-2-yl)-3-hydroxybutyl)malonate, 95+%, 1g

4-(Chloromethyl)-7-methyl-2H-1-benzopyran-2-one, 97%, 250mg

Ethyl 2-Chloro-5-nitrobenzoate, 90.0%, 5g

2-(3-Bromophenyl)-1H-indole, 95.0%, 1g

6-Bromo-4-methoxypyrazolo[1,5-a]pyridine-3-carbaldehyde, 95.0%, 1g

2-(4-bromophenyl)-N,N-dimethylacetamide, 95.0%, 25g

3-(4-Fluorophenyl)-3-methylbutanoic acid, 100mg

iScope IS.1159-PLPHi Biocular for phase contrast with Plan phase IOS objectives, Rackless cross table and Photo attachment (infinity - ergonomic tilting head)

Palladium on SH Silica Gel (0.1mmol/g)1g